Notably, it has been proposed as a candidate tumor suppressor gene in several cancer types, including ovarian cancer [57], although conflicting results in different tumors suggest that it IGFBP7 functions may be a “double-edged sword” in cancer proliferation, progression, and prognosis. Here, IGFBP7 is linked to ovarian cancer.